Nevro Corp (NVRO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 03-2024 | 12-2023 | 09-2023 | 06-2023 | 03-2023 | |
| Sales | 101,899 | 116,176 | 103,862 | 108,809 | 96,327 |
| Cost of Goods | 30,371 | 34,699 | 34,346 | 34,366 | 31,703 |
| Gross Profit | 71,528 | 81,477 | 69,516 | 74,443 | 64,624 |
| Operating Expenses | 107,733 | 93,963 | 95,421 | 100,448 | 101,650 |
| Operating Income | -35,834 | -11,787 | -25,559 | -25,639 | -36,323 |
| Interest Expense | 6,512 | 3,165 | 1,618 | 1,618 | 1,613 |
| Other Income | 17,319 | -607 | 3,828 | 3,010 | 3,232 |
| Pre-tax Income | -25,027 | -15,559 | -23,349 | -24,247 | -34,704 |
| Income Tax | 382 | -6,578 | 130 | 477 | 325 |
| Net Income Continuous | -25,409 | -8,981 | -23,479 | -24,724 | -35,029 |
| Net Income | $-25,409 | $-8,981 | $-23,479 | $-24,724 | $-35,029 |
| EPS Basic Total Ops | -0.70 | -0.24 | -0.65 | -0.69 | -0.98 |
| EPS Basic Continuous Ops | -0.70 | -0.24 | -0.65 | -0.69 | -0.98 |
| EPS Diluted Total Ops | -0.70 | -0.24 | -0.65 | -0.69 | -0.98 |
| EPS Diluted Continuous Ops | -0.70 | -0.24 | -0.65 | -0.69 | -0.98 |
| EPS Diluted Before Non-Recurring Items | N/A | -0.15 | -0.65 | -0.69 | -0.98 |
| EBITDA(a) | $-32,110 | $-9,415 | $-23,386 | $-23,437 | $-34,264 |